{'fraction_non_alphanumeric': 0.019384264538198404, 'fraction_numerical': 0.002280501710376283, 'mean_word_length': 5.226950354609929, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Factors involved in gingival hyperplasia caused by diphenyl hydantoin].

BACKGROUND
The objective of this clinical study is to evaluate the relationship between the degree of the phenytoin-induced gingival overgrowth (GO) and factors like bacterial plaque, the "individual predisposition" to develop GO and multiple drug based therapy.


MATERIALS AND METHODS
During a one year period we examined 20 epileptic patients taking phenytoin alone or in association with other drugs; they underwent initial therapy and in some cases periodontal surgery.


RESULTS
The long-term control showed that a better oral hygiene and an association of drugs may reduce the gingival overgrowth but not eliminate it.


CONCLUSION
A determining factor in developing GO seems to be the "individual predisposition" probably due to the presence of a fibroblast subpopulation sensitive to phenytoin.